Date Filed | Type | Description |
10/13/2023 |
8-K
| Quarterly results |
10/05/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
10/04/2023 |
4
| Kaye Mark (EVP & CFO Designate) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 18,174 shares
@ $0 Granted 2,102 shares
@ $0 Granted 8,076 options to buy
@ $440.19, valued at
$3.6M
|
|
09/29/2023 |
10-Q/A
| Quarterly Report for the period ended June 30, 2023 [amend] |
08/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/19/2023 |
8-K
| Quarterly results |
06/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
05/12/2023 |
4
| PERU RAMIRO G (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| HAY LEWIS III (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| Dixon Robert L JR (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| Neri Antonio F (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| Schneider Ryan M. (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| Jallal Bahija (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| Tallett Elizabeth E (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| STRABLE-SOETHOUT DEANNA D (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| CLARK R KERRY (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/12/2023 |
4
| DeVore Susan D. (Director) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Granted 457 shares
@ $0 |
|
05/11/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
04/19/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/19/2023 |
8-K
| Quarterly results |
03/31/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/31/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/27/2023 |
4
| MCCARTHY GLORIA M (EVP & Chief Administrative Off) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Sold 600 shares
@ $440.78, valued at
$264.5k
Sold 500 shares
@ $442.02, valued at
$221k
Sold 1,800 shares
@ $443.27, valued at
$797.9k
Sold 3,000 shares
@ $444.33, valued at
$1.3M
Sold 5,573 shares
@ $445.3, valued at
$2.5M
Sold 3,625 shares
@ $446.06, valued at
$1.6M
|
|
03/22/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
03/13/2023 |
4
| Kendrick Charles Morgan JR (EVP & President, Commercial) has filed a Form 4 on Elevance Health, Inc.
Txns:
| Sold 2,314 shares
@ $462.22, valued at
$1.1M
|
|
02/22/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 5.3% stake in ELEVANCE HEALTH INC |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9% stake in Elevance Health Inc. |
02/08/2023 |
8-K
| Quarterly results |
01/30/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
01/30/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
|